Nutex Health Inc (NUTX) Financials

$190.41

$-2.84 (-1.47%)

As on 08-Sep-2026 15:30EDT

Market cap

$1,323 Mln

Revenue (TTM)

$847 Mln

P/E Ratio

7.5

P/B Ratio

3.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	846.72	875.26	479.95	247.65	219.29	331.53
Cost of Revenue	412.69	430.98	283.69	212.87	203.87	152.25
Gross Profit	434.03	444.28	196.26	34.77	15.42	179.28
Operating Expenses	69.76	168.66	65.64	66.55	422.02	9.02
Operating Profit (EBIT)	364.27	275.63	130.62	-31.77	-406.60	170.26
Other Income	--	--	--	--	-0.56	--
Profit before Tax	343.48	244.78	109.75	-48.49	-419.65	169.49
Provision for Tax	70.99	64.42	14.48	-5.07	13.09	0.97
Profit after Tax (Net Income)	179.92	70.79	52.18	-45.79	-424.78	132.59
Minority Interest	-92.57	-109.57	-43.09	-2.55	-7.96	-35.93
Consolidated Profit	--	--	--	--	-424.78	132.59

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	394.32	329.45	146.34	61.45	95.86	114.65
Minority Interest	-92.57	--	--	--	24.46	--
Non-Current Liabilities	340.10	337.18	312.56	260.83	256.56	165.38
Current Liabilities	117.22	157.91	140.87	58.31	54.86	37.69
Total Liabilities	1,081.85	918.53	655.32	398.25	431.75	394.65

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	378.98	379.71	362.84	307.40	333.78	240.63
Current Assets	585.65	538.81	292.48	90.85	97.97	154.02
Total Assets	1,081.85	918.53	655.32	398.25	431.75	394.65
Total Debt*	347.34	351.39	340.30	275.76	267.20	178.55
Net Current Assets	468.43	380.90	151.61	32.54	43.11	116.32

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	248.13	23.15	1.26	50.61	173.43
Cash Flow from Investing Activities	--	-5.24	-2.67	-11.24	-4.34	-36.98
Cash from Financing Activities	--	-97.95	1.09	-2.27	-48.13	-125.85
Net Cash Inflow / Outflow	--	--	--	--	-1.86	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	25.27	9.86	10.23	-10.86	-86.38	33.55
Cash EPS ($)	--	12.72	13.95	-7.02	-83.71	35.49
Adjusted Book Value ($)	--	45.90	28.70	14.58	19.49	29.01
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	34.57	4.54	0.30	10.29	43.89
Free Cash Flow per Share ($)	--	34.22	4.09	-1.95	7.32	34.54

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	12.13	12.67	-13.08	-129.45	50.12
ROE (%)	24.14	29.76	50.22	-58.21	-403.57	132.29
ROA (%)	16.99	9.00	9.91	-11.03	-102.80	37.71
EBIT Margin (%)	42.91	30.51	27.02	-12.99	-185.67	52.99
Net Margin (%)	21.25	8.09	10.87	-18.49	-194.20	39.99
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	6.88	0.82	0.94	0.13	-0.34	0.21
EBIT Growth (%)	96.05	105.90	503.07	92.10	-331.75	15.45
Net Profit Growth (%)	263.32	35.67	213.96	89.22	-420.36	25.12
EPS Growth (%)	135.41	-0.04	1.94	0.87	-3.57	202.82
Book Value Growth (%)	57.44	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	7.49	16.69	3.10	-0.02	-0.02	0.12
Price / Book Value	3.43	3.59	1.10	0.01	0.10	0.14
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	3.89	4.69	7.86	-17.45	-0.61	0.87
Close Price ($)	170.89	164.62	31.69	1.80	19.00	41.20
High Price ($)	193.07	193.07	40.68	21.20	528.00	49.80
Low Price ($)	77.21	28.82	0.75	1.70	5.00	14.50
Market Cap ($ Cr)	1,323.30	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.08	1.07	2.33	4.49	2.79	1.56
Short term debt to equity ratio	0.05	0.07	0.19	0.33	0.22	0.11
Current Ratio	5.00	3.41	2.08	1.56	1.79	4.09
Quick Ratio	4.96	3.39	2.06	1.50	1.72	4.01
Interest Coverage	18.36	12.01	6.51	-1.97	-32.60	28.35

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	42.13	37.18	49.18	25.35	26.59	34.61
Asset Turnover	0.80	1.11	0.91	0.60	0.53	0.94
Receivable days	--	117.15	113.71	89.30	144.13	122.78
Inventory Days	--	2.42	4.02	5.94	5.69	5.45
Payable days	--	26.66	25.26	42.22	37.25	31.53
Cash Conversion Cycle	--	92.91	92.46	53.02	112.57	96.70

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.